As the world watches the US election, the appeal of America is diminished
Is China An Existential Threat To America?
Human Capital: Uber Eats hit with claims of ‘reverse racism’
Central Banks Sell Gold For The First Time In 10 Years Due To Just Two Countries
Buchanan: What The Next President Faces
Week Ahead – Election Time!
Digital Banking Challenges: Where Will The Next Curveball Come From?
Indian pharma is being squeezed – and it's bad news for drug access in developing countries
Reliance Jio Platforms tops 400M subscribers, explores expanding services outside of India
Covid-19 roundup: Flush with $486M contract, AstraZeneca signs Lonza up to manufacture antibodies; BioNTech's Ugur Sahin expects vaccine data 'in a fortnight'
Global coronavirus cases rise by single-day record of half a million
Global COVID-19 Cases Near 45 Million After Another Record Day: Live Updates
How Can Startups Best Use PR on a Limited Runway?
Sinch announces Conversation API to bring together multiple messaging tools
Stocks Struggle To Stabilize After Worst Rout Since June
Value Investing Trend Shows Investors Should Consider Diversified Investments
News briefing: SpringWorks, Jazz exchange $35M and PTSD drug; Dr. Reddy's says cyberattack was ransomware
Europe On The Cusp Of New Lockdowns As Brussels Plots Pan-EU Restrictions: Live Updates
Akamai's 3Q Sales Spike 12%, Fueled By Cloud Security Demand
Spanish Doctors Stage First Walkout In 25 Years To Protest Government's New COVID-19 Order
Scientists discover new organic compounds that could have helped form the first cells
How to prevent COVID-19 ‘superspreader’ events indoors this winter
Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot
Thanks to COVID-19, emissions and coal use may have peaked in 2019
Futures Rebound From Monday's Plunge On Strong Earnings, Mega Merger
Morgan Stanley Models The Number Of Covid Infections In 2021: Here Are The Bull, Bear And Base Cases
Second Covid wave swells across U.S. and Europe
Futures Tumble, European Tech Stocks Plunge Amid Surging Virus Cases, Reflation Trade Fears
Carlyle To Snap Up Majority Stake In Funds Network Calastone; Analyst Says Buy
Convalescent plasma misses the mark in phase 2 trial